JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Woldbye, D. P. D.
Right arrow Articles by Madsen, T. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Woldbye, D. P. D.
Right arrow Articles by Madsen, T. M.

Vol. 284, Issue 2, 633-636, February 1998

Neuropeptide Y Attenuates Naloxone-Precipitated Morphine Withdrawal via Y5-like Receptors1

David P. D. Woldbye, Kristian Klemp and Torsten M. Madsen

Laboratory of Neuropharmacology, Department of Pharmacology, University of Copenhagen, (D.P.D.W., K.K.); Laboratory for Experimental Neuropsychiatry, Department of Psychiatry, University Hospital, Rigshospitalet, Copenhagen (T. M. M.), Denmark.

The effects of intracerebroventricular injection of neuropeptide Y (NPY) and various NPY-related peptides were studied on naloxone-precipitated withdrawal from morphine in rats. The withdrawal reaction was assessed using an overall motor score, including jumping, wet dog shakes and other motor-related signs as well as a nonmotor score. At doses of 3, 6 or 12 nmol, NPY strongly and dose-dependently reduced the motor score. A less prominent inhibitory effect was revealed on the nonmotor score. At 6 nmol, [Leu31,Pro34]-NPY, NPY 3-36, peptide YY and human pancreatic polypeptide all significantly attenuated the motor score, whereas NPY 13-36 was without effect. This pharmacological profile suggests that the antiwithdrawal effect of NPY is mediated via the recently cloned Y5 receptor. Our data are consistent with a potential role for NPY and Y5-like receptors in basic mechanisms and as a therapeutic target in opioid dependence and withdrawal.

0022-3565/98/2842-0633$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J. Neurosci.Home page
H. Houshyar, S. Manalo, and M. F. Dallman
Time-Dependent Alterations in mRNA Expression of Brain Neuropeptides Regulating Energy Balance and Hypothalamo-Pituitary-Adrenal Activity after Withdrawal from Intermittent Morphine Treatment
J. Neurosci., October 20, 2004; 24(42): 9414 - 9424.
[Abstract] [Full Text] [PDF]

Home page
 Alcohol AlcoholHome page
D. P. D. Woldbye, J. Ulrichsen, S. Haugbol, and T. G. Bolwig
ETHANOL WITHDRAWAL IN RATS IS ATTENUATED BY INTRACEREBROVENTRICULAR ADMINISTRATION OF NEUROPEPTIDE Y
Alcohol Alcohol., July 1, 2002; 37(4): 318 - 321.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics.